Health Care Contracts & Agreements
155,427 Contracts from 2,100 Health Care Companies
- Biotechnology (58,500 contracts from 663 companies)
- Health Care Equipment & Supplies (28,714 | 359)
- Health Care Providers & Services (25,822 | 479)
- Health Care Technology (4,883 | 71)
- Life Sciences Tools & Services (5,049 | 64)
- Pharmaceuticals (32,459 | 464)
- Share Repurchase Agreement, dated as of April 30, 2024, by and between DaVita Inc. and Berkshire Hathaway Inc (DaVita Inc., Filed With SEC on May 1, 2024)
- Form of Stock Option Grant Notice and Option Agreement for grants made to Kevin Gorman on or after February 13, 2024 made under the Neurocrine Biosciences, Inc. 2020 Equity... (NEUROCRINE BIOSCIENCES INC, Filed With SEC on May 1, 2024)
- Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement for grants on or after February 13, 2024 made under the Neurocrine Biosciences, Inc.... (NEUROCRINE BIOSCIENCES INC, Filed With SEC on May 1, 2024)
- Form of 2024 Performance Share Unit Award Agreement under the Companys Amended and Restated 2011 Long-Term Incentive Plan (Organic Net Sales Growth) (Boston Scientific, Filed With SEC on May 1, 2024)
- Form of 2024 Performance Share Unit Award Agreement under the Companys Amended and Restated 2011 Long-Term Incentive Plan (Total Shareholder Return) (Boston Scientific, Filed With SEC on May 1, 2024)
- Form of 2024 Global Restricted Stock Unit Award Agreement under the Companys Amended and Restated 2011 Long-Term Incentive Plan (Boston Scientific, Filed With SEC on May 1, 2024)
- Form of 2024 Global Non-Qualified Stock Option Agreement under the Companys Amended and Restated 2011 Long-Term Incentive Plan (Boston Scientific, Filed With SEC on May 1, 2024)
- Amended and Restated Executive Employment Agreement dated April 29, 2024 between the Company and Mr. Fletcher Payne (Aptose Biosciences Inc., Filed With SEC on May 1, 2024)
- Amended and Restated Executive Employment Agreement dated April 29, 2024 between the Company and Dr. Rafael Bejar (Aptose Biosciences Inc., Filed With SEC on May 1, 2024)
- Second Amended and Restated Executive Employment Agreement dated April 29, 2024 between the Company and Dr. William G. Rice (Aptose Biosciences Inc., Filed With SEC on May 1, 2024)
- Form of Restricted Stock Unit Award Agreement under Sarepta Therapeutics, Inc. 2024 Employment Commencement Incentive Plan (Sarepta Therapeutics, Inc., Filed With SEC on May 1, 2024)
- Form of Stock Option Award Agreement under Sarepta Therapeutics, Inc. 2024 Employment Commencement Incentive Plan (Sarepta Therapeutics, Inc., Filed With SEC on May 1, 2024)
- Term Loan Credit Agreement, dated March 25, 2024, by and among the Registrant, the lenders party thereto and Bank of America, N.A., as administrative agent (CVS, Filed With SEC on May 1, 2024)
- Change in Control Agreement effective as of (CVS, Filed With SEC on May 1, 2024)
- Form of Share Unit Award Agreement (Outperformance Performance Restricted Share Units) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (Bausch & Lomb Corp, Filed With SEC on May 1, 2024)
- Form of Stock Option Grant Agreement (Non-Qualified Stock Option) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, by and between Bausch +Lomb Corporation and... (Bausch & Lomb Corp, Filed With SEC on May 1, 2024)
- Form of Share Unit Award Agreement (Restricted Share Units) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, by and between Bausch +Lomb Corporation and Brenton L.... (Bausch & Lomb Corp, Filed With SEC on May 1, 2024)
- Form of Share Unit Award Agreement (Performance Restricted Share Units Relative TSR) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, by and between Bausch +Lomb... (Bausch & Lomb Corp, Filed With SEC on May 1, 2024)
- Form of Share Unit Award Agreement (Performance Restricted Share Units Organic Revenue Growth) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, by and between... (Bausch & Lomb Corp, Filed With SEC on May 1, 2024)
- Form of Stock Option Grant Agreement (Non-Qualified Stock Option) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (Bausch & Lomb Corp, Filed With SEC on May 1, 2024)
- Form of Share Unit Award Agreement (Restricted Share Units) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (Bausch & Lomb Corp, Filed With SEC on May 1, 2024)
- Form of Share Unit Award Agreement (Performance Restricted Share Units Relative TSR) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (Bausch & Lomb Corp, Filed With SEC on May 1, 2024)
- Form of Share Unit Award Agreement (Performance Restricted Share Units Organic Revenue Growth) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (Bausch & Lomb Corp, Filed With SEC on May 1, 2024)
- Employment Agreement dated as of April 24, 2023, by and between Bausch + Lomb Corporation and Andrew Stewart (Bausch & Lomb Corp, Filed With SEC on May 1, 2024)
- Employment Agreement dated as of April 24, 2023, by and between Bausch + Lomb Corporation and A. Robert D. Bailey (Bausch & Lomb Corp, Filed With SEC on May 1, 2024)
- Form of Securities Purchase Agreement (Innovative Eyewear Inc, Filed With SEC on May 1, 2024)
- Form of PA Warrant (Innovative Eyewear Inc, Filed With SEC on May 1, 2024)
- Form of Purchase Warrant (Innovative Eyewear Inc, Filed With SEC on May 1, 2024)
- Offer Letter Agreement, dated March 5, 2024, between DH Dental Employment Services, LLC and Stephen Keller (Envista Holdings Corp, Filed With SEC on May 1, 2024)
- Settlement and Release Agreement dated as of May 1, 2024 by and between IMAC Holdings, Inc. and Theralink Technologies, Inc (IMAC Holdings, Inc., Filed With SEC on May 1, 2024)
- Form of Securities Purchase Agreement dated as of April 30, 2024, by and between IMAC Holdings, Inc. and the Investor signatory thereto, with schedule of signatories (IMAC Holdings, Inc., Filed With SEC on May 1, 2024)
- April 3, 2024 Mutual Settlement and Release Agreement, Blue Lake Partners, LLC (Electromedical Technologies, Inc, Filed With SEC on May 1, 2024)
- Form of Placement Agent Warrant (May 2024) (AVENUE THERAPEUTICS, INC., Filed With SEC on May 1, 2024)
- Form of New Series D Warrant (May 2024) (AVENUE THERAPEUTICS, INC., Filed With SEC on May 1, 2024)
- Form of New Series C Warrant (May 2024) (AVENUE THERAPEUTICS, INC., Filed With SEC on May 1, 2024)
- Amendment No. 1 to Sales Agreement, dated as of May 1, 2024, between Corvus Pharmaceutical, Inc. and Jefferies LLC (Corvus Pharmaceuticals, Inc., Filed With SEC on May 1, 2024)
- Lease Agreement, dated January 8, 2024 by and between Brickell Key Center, LLC and Summit Therapeutics, Inc (Summit Therapeutics Inc., Filed With SEC on May 1, 2024)
- Amended Employment Agreement, dated October 31, 2023 by and between Summit Therapeutics Inc. and Mahkam Zanganeh (Summit Therapeutics Inc., Filed With SEC on May 1, 2024)
- First Amendment to Employment Agreement by and between Monica R. Thomas and the Registrant effective as of April 1, 2024 (G1 Therapeutics, Inc., Filed With SEC on May 1, 2024)
- Second Amendment to Employment Agreement by and between Terry Murdock and the Registrant effective as of April 1, 2024 (G1 Therapeutics, Inc., Filed With SEC on May 1, 2024)
